skip to main content

News Archive

Date: 06/19/2024
A brief recap of Rogel Cancer Center researcher presentations at ASCO 2024 in Chicago.
Date: 06/06/2024
According to preliminary findings from a survey led by Rogel researcher Steven Katz, M.D., MPH, a professor of health management and policy, the ability to fully realize genetic testing among family members of patients is mitigated by several factors.
Date: 05/30/2024
The University of Michigan Rogel Cancer Center has awarded four Michigan community organizations a total of $200,000 in grants for projects designed to improve cancer screening and tobacco cessation among populations experiencing cancer disparities. The grants will enable each organization to implement evidence-based interventions within the community they serve.
Date: 05/22/2024
Check out the list of U-M presenters to support your colleagues. Connect with researchers on X/Twitter using #AACR24. Be sure to tag @UMRogelCancer.
Date: 05/06/2024
Do all thyroid cancer survivors need the same level of follow-up care and monitoring? With a new $3.3 million grant from the National Cancer Institute, Megan Haymart, M.D., will identify survivors at different risks of recurrence and develop a system for long-term monitoring based on that risk.
Date: 04/29/2024
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.
Date: 04/11/2024
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It’s a cancer that’s considered incurable, with survival ranging from less than a year to more than a decade, depending on the extent and aggressiveness of the tumors.
Date: 04/10/2024
Highlights from Rogel's presence at the 2024 AACR Annual Meeting
Date: 04/10/2024
Abhijit Parolia, M.S., Ph.D., assistant professor of pathology and urology at the University of Michigan Health Rogel Cancer Center, was named at NextGen Star by the American Association of Cancer Research.
Date: 04/09/2024
Mats Ljungman, Ph.D., Rogel researcher and professor of radiation oncology, shared research on KLIPP, a new technique in precision medicine using CRISPR to target weak spots in cancer cells, at the American Association of Cancer Research's Annual Meeting.